AKAP13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.153900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.168610E-01
Normal-vs-Stage2
8.024000E-02
Normal-vs-Stage3
1.108650E-01
Normal-vs-Stage4
6.326600E-01
Stage1-vs-Stage2
5.323000E-01
Stage1-vs-Stage3
4.818800E-01
Stage1-vs-Stage4
2.598800E-01
Stage2-vs-Stage3
2.284400E-01
Stage2-vs-Stage4
3.256200E-01
Stage3-vs-Stage4
1.795790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.948200E-02
Normal-vs-AfricanAmerican
7.104400E-01
Normal-vs-Asian
1.515630E-01
Caucasian-vs-AfricanAmerican
3.737400E-01
Caucasian-vs-Asian
6.290000E-01
AfricanAmerican-vs-Asian
2.653600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.255600E-02
Normal-vs-Female
7.322500E-02
Male-vs-Female
4.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.622400E-01
Normal-vs-Age(41-60Yrs)
2.115200E-01
Normal-vs-Age(61-80Yrs)
3.883700E-02
Normal-vs-Age(81-100Yrs)
2.376200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.028600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.454400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.338000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.420300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.593800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.593000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.920300E-02
Normal-vs-Daily Drinker
2.985700E-02
Normal-vs-Weekly Drinker
1.128000E-01
Normal-vs-Occasional Drinker
4.680100E-02
Normal-vs-Social Drinker
1.592990E-01
Non Drinker-vs-Daily Drinker
3.559600E-01
Non Drinker-vs-Weekly Drinker
8.793800E-01
Non Drinker-vs-Occasional Drinker
6.502200E-01
Non Drinker-vs-Social Drinker
6.225600E-01
Daily Drinker-vs-Weekly Drinker
3.212200E-01
Daily Drinker-vs-Occasional Drinker
6.562200E-01
Daily Drinker-vs-Social Drinker
1.806800E-01
Weekly Drinker-vs-Occasional Drinker
5.599400E-01
Weekly Drinker-vs-Social Drinker
7.505000E-01
Occasional Drinker-vs-Social Drinker
3.558000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.349600E-01
Normal-vs-Grade 2
1.188000E-01
Normal-vs-Grade 3
1.452620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.688750E-01
Grade 1-vs-Grade 3
2.922000E-01
Grade 1-vs-Grade 4
5.349600E-01
Grade 2-vs-Grade 3
6.270200E-01
Grade 2-vs-Grade 4
1.188000E-01
Grade 3-vs-Grade 4
1.452620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.690000E-02
Normal-vs-NonDiabetic
4.134400E-02
Diabetic-vs-NonDiabetic
8.983000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.077210E-01
Normal-vs-NoPancreatitis
4.721700E-02
Pancreatitis-vs-NoPancreatitis
6.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.123800E-02
Normal-vs-N1
9.611500E-02
N0-vs-N1
4.521800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.846200E-02
Normal-vs-TP53-NonMutant
1.133800E-01
TP53-Mutant-vs-TP53-NonMutant
8.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
